MADEDDU, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 250
EU - Europa 79
AS - Asia 74
SA - Sud America 8
AF - Africa 1
Totale 412
Nazione #
US - Stati Uniti d'America 248
SG - Singapore 51
CN - Cina 20
DE - Germania 19
IT - Italia 19
SE - Svezia 15
FI - Finlandia 7
GB - Regno Unito 5
BE - Belgio 4
BR - Brasile 4
UA - Ucraina 3
AR - Argentina 2
AT - Austria 2
RU - Federazione Russa 2
CA - Canada 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
IM - Isola di Man 1
IN - India 1
KE - Kenya 1
KZ - Kazakistan 1
NL - Olanda 1
PE - Perù 1
VE - Venezuela 1
VN - Vietnam 1
Totale 412
Città #
Santa Clara 34
Singapore 30
Fairfield 26
Ashburn 21
Chandler 21
Beijing 14
Woodbridge 13
Houston 12
Bremen 8
Princeton 8
Seattle 8
Cambridge 6
Ferrara 6
Helsinki 6
Milan 6
San Diego 6
Shanghai 6
Wilmington 6
Brussels 4
Falkenstein 4
London 4
Los Angeles 4
Augusta 3
Boardman 3
Nuremberg 3
Norwalk 2
Redwood City 2
Ann Arbor 1
Buenos Aires 1
Caracas 1
Caxias do Sul 1
Diadema 1
Douglas 1
Falls Church 1
Forlì 1
Frankfurt am Main 1
Grosseto 1
Kyiv 1
La Plata 1
Lappeenranta 1
Lima 1
Nairobi 1
Napoli 1
Olomouc 1
Orlando 1
Passo Fundo 1
Pisa 1
Redmond 1
Regina 1
Rudnyy 1
San José 1
San Mateo 1
Stockholm 1
Uberlândia 1
Wandsworth 1
Totale 294
Nome #
Evolution of HIV-1 tropism at quasispecies level after 5 years of combination antiretroviral therapy in patients always suppressed or experiencing episodes of virological failure 76
Longitudinal analysis of HIV-1 coreceptor tropism by single and triplicate HIV-1 RNA and DNA sequencing in patients undergoing successful first-line antiretroviral therapy 68
TB meningitis in HIV-positive patients in Europe and Argentina: Clinical dutcome and factors associated with mortality 62
Predictors of access and response to DAA in a cohort of human immunodeficiency virus/hepatitis C virus co-infected patients in Italy 59
Evolution and reversibility of renal function after switch from TDF to TAF regimens 44
Serious liver events and liver-related deaths in HIV/HCV co-infected patients with diabetes: data from the ICONA Foundation Cohort Study. 44
Two years of exposure to elvitegravir/cobicistat/emtricitabine/tenofovir(E/C/FTC/TDF): an overview of the trend in laboratory parameters in clinical practice. 34
Low Body Mass Index (BMI) in ART naïve HIV-positive subjects and risk of virologic failure and drug discontinuation: data from the ICONA Foundation cohort. 33
Totale 420
Categoria #
all - tutte 4.397
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.397


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202024 0 0 0 0 0 0 0 0 0 7 13 4
2020/202168 3 15 6 4 13 1 3 5 1 5 7 5
2021/202258 2 4 0 1 10 4 0 4 1 7 1 24
2022/202365 9 5 6 6 11 7 6 5 4 0 6 0
2023/202442 2 5 3 2 0 9 0 5 1 0 0 15
2024/2025142 2 2 15 10 23 34 1 8 29 18 0 0
Totale 420